Pfizer wants manufacturing 'efficiencies' in 2013
Pfizer's CEO has raised the possibility of more cost cutting in manufacturing operations in 2013 to offset the impact of patent loss for key products.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs